pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 19·1 min read
save

Former Stanford President Marc Tessier-Lavigne Addresses Allegations in New Book

May 19, 2026·read at STAT ↗Neutral

Former Stanford President Marc Tessier-Lavigne, now chief executive of AI drug‑discovery startup Xaira, spoke publicly for the first time at the STAT Breakthrough Summit West in San Francisco.

During the session, STAT reporter Matthew Herper read excerpts from Theo Baker’s new book “How to Rule the World,” which allege that Tessier-Lavigne was forced to resign because of shortcomings in his oversight of scientists and his handling of the controversy.

The book claims the board criticized his “admit‑nothing, deny‑everything” approach and suggests the university’s investigation omitted another incident that contributed to his ouster.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Marc Tessier-Lavigne addresses new book’s allegations about his conduct in Stanford misconduct case”

read at STAT ↗
541 words · retrieved May 20
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
ASTRAZENECA
topics
Approval2Hypertension

related stories

  • Sep 23Amgen asset from $27.8B Horizon buy scores in Phase 3 Sjögren's studyBioSpace
  • Sep 22Amgen’s Horizon-acquired fusion protein eases Sjögren's severity in ph. 3 winFierce Biotech
  • Sep 8Roivant surges on ‘exceptional’ results; Bristol Myers touts first-of-its-kind CAR-T therapyBioPharma Dive
  • Sep 8STAT+: FDA approves AstraZeneca breast cancer drugSTAT
  • Aug 17STAT+: Akeso and Summit’s lung cancer drug shows worsening tumor-progression benefitSTAT